E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/2/2006 in the Prospect News Biotech Daily.

Align upgraded by JMP to market outperform

Align Technology, Inc. was upgraded to market outperform from market perform by JMP Securities analyst Anthony Ostrea based on JMP's proprietary survey, March-quarter report from Align and favorable risk/reward. Align reported better-than-expected U.S. Invisalign shipments in the March quarter. JMP forecasts 2006-2008 revenue of $204 million (from $202 million), $226 million (from $227 million), and $248 million (from $260 million). Shares of the Santa Clara, Calif., dental products company were down 12 cents, or 1.35%, at $8.77 on volume of 753,691 shares versus the three-month running average of 581,864 shares. (Nasdaq: ALGN)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.